Qin Qin, Furong Wei, Baosheng Li
Department of Radiation Oncology, Shandong Cancer Hospital, Shandong University, Jiyan Road 440, Jinan 250117, P,R, China.
J Exp Clin Cancer Res. 2014 Jun 9;33(1):50. doi: 10.1186/1756-9966-33-50.
MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression post-transcriptionally. miRNAs can be induced by a variety of stresses such as hypoxia, and are involved in diverse biological processes including differentiation, cell proliferation, cell death, and tumorigenesis. Hypoxia, a common feature of tumor microenvironment, can induce a number of miRNAs expression. miRNA-210 (miR-210) is one of the hypoxia-regulated-miRNAs, which has been investigated extensively in cancer. However, paradoxically opposing results were documented regarding whether it is an oncogene or a tumor suppressor, and whether it is a positive or negative prognostic biomarker. In the present review, we focus on the following investigations of miR-210: 1) its functions of as an oncogene, 2) its functions as a tumor suppressor, 3) its functions in mitochondrial metabolism, and finally, the diagnostic and prognostic value of miR-210 in cancer researches.
微小RNA(miRNA)是一类小的非编码RNA,可在转录后水平调控基因表达。miRNA可由多种应激因素如缺氧诱导产生,并参与包括分化、细胞增殖、细胞死亡和肿瘤发生在内的多种生物学过程。缺氧是肿瘤微环境的一个常见特征,可诱导多种miRNA表达。miRNA-210(miR-210)是缺氧调节的miRNA之一,在癌症研究中已得到广泛研究。然而,关于它是癌基因还是肿瘤抑制基因,以及它是阳性还是阴性预后生物标志物,却有相互矛盾的结果报道。在本综述中,我们重点关注以下关于miR-210的研究:1)其作为癌基因的功能;2)其作为肿瘤抑制基因的功能;3)其在线粒体代谢中的功能;最后是miR-210在癌症研究中的诊断和预后价值。